• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

κ-阿片受体激动剂U-50,488H抗心律失常作用的电生理基础。

An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H.

作者信息

Pugsley M K, Saint D A, Walker M J

机构信息

Department of Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, Canada.

出版信息

Eur J Pharmacol. 1994 Aug 22;261(3):303-9. doi: 10.1016/0014-2999(94)90121-x.

DOI:10.1016/0014-2999(94)90121-x
PMID:7813552
Abstract

This study examined the actions of the selective kappa-opioid receptor agonist, U-50,488H, on voltage activated Na+ and K+ currents in isolated rat cardiac myocytes. U-50,488H produced a concentration-dependent block of the transient Na+ current with an ED50 of about 15 microM, and, at higher concentrations (40-50 microM), a block of the plateau K+ current and an increase in the rate of decay of the transient K+ current. In addition U-50,488H produced a hyperpolarising shift in the inactivation curve for the transient Na+ current without altering the voltage dependence for activation and without an effect on the voltage dependence of inactivation or activation of K+ currents. The block of Na+ currents by U-50,488H showed pronounced use dependence. The kappa-opioid receptor antagonist MR2266 did not itself produce any change in the Na+ or K+ currents and did not change the channel blocking properties of U-50,488H. Thus, since the antiarrhythmic actions of U-50,488H are not blocked by MR2266 or naloxone, the effects of U-50,488H to block Na+ and K+ currents are the most likely reasons for its antiarrhythmic actions, rather than an action at kappa-opioid receptors.

摘要

本研究检测了选择性κ-阿片受体激动剂U-50,488H对离体大鼠心肌细胞电压激活的Na⁺和K⁺电流的作用。U-50,488H对瞬时Na⁺电流产生浓度依赖性阻滞,半数有效浓度(ED50)约为15μM,且在较高浓度(40 - 50μM)时,对平台期K⁺电流产生阻滞,并使瞬时K⁺电流的衰减速率增加。此外,U-50,488H使瞬时Na⁺电流的失活曲线发生超极化偏移,而不改变激活的电压依赖性,且对K⁺电流的失活或激活的电压依赖性无影响。U-50,488H对Na⁺电流的阻滞表现出明显的使用依赖性。κ-阿片受体拮抗剂MR2266本身对Na⁺或K⁺电流无任何影响,也不改变U-50,488H的通道阻滞特性。因此,由于U-50,488H的抗心律失常作用不受MR2266或纳洛酮的阻断,U-50,488H阻断Na⁺和K⁺电流的作用最有可能是其抗心律失常作用的原因,而非作用于κ-阿片受体。

相似文献

1
An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H.κ-阿片受体激动剂U-50,488H抗心律失常作用的电生理基础。
Eur J Pharmacol. 1994 Aug 22;261(3):303-9. doi: 10.1016/0014-2999(94)90121-x.
2
Sodium channel-blocking properties of spiradoline, a kappa receptor agonist, are responsible for its antiarrhythmic action in the rat.κ受体激动剂spiradoline的钠通道阻滞特性是其在大鼠体内抗心律失常作用的原因。
J Cardiovasc Pharmacol. 1998 Dec;32(6):863-74. doi: 10.1097/00005344-199812000-00002.
3
Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.κ-激动剂U-50,488H在有无阿片受体阻断情况下的心血管作用
Br J Pharmacol. 1992 Mar;105(3):521-6. doi: 10.1111/j.1476-5381.1992.tb09012.x.
4
Effects of U50,488H on transient outward and ultra-rapid delayed rectifier K+ currents in young human atrial myocytes.U50,488H对年轻人类心房肌细胞瞬时外向钾电流和超快速延迟整流钾电流的影响。
Eur J Pharmacol. 2003 Jul 25;473(2-3):97-103. doi: 10.1016/s0014-2999(03)01974-5.
5
Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart.U50,488H对缺血/再灌注大鼠心脏的心脏保护和抗心律失常作用。
Heart Vessels. 2007 Sep;22(5):335-44. doi: 10.1007/s00380-007-0983-z. Epub 2007 Sep 20.
6
The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.κ-阿片类药物U-50,488H在佐剂性关节炎中的抗关节炎作用部位:局部给药的重要性
Br J Pharmacol. 1996 Aug;118(7):1754-60. doi: 10.1111/j.1476-5381.1996.tb15601.x.
7
Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.κ-阿片受体刺激对灌注大鼠心脏的抗心律失常作用:cAMP依赖性途径的参与
J Mol Cell Cardiol. 1999 Oct;31(10):1809-19. doi: 10.1006/jmcc.1999.1014.
8
U-50,488H, a kappa opioid receptor agonist, is a more potent blocker of cardiac sodium channels than lidocaine.U-50488H,一种κ阿片受体激动剂,是一种比利多卡因更强效的心脏钠通道阻滞剂。
Proc West Pharmacol Soc. 2000;43:47-50.
9
[Delayed electrical uncoupling is involved in kappa-opioid receptor activation -induced cardioprotective effect in the isolated rat heart].[延迟电去耦联参与κ-阿片受体激活诱导的离体大鼠心脏心脏保护作用]
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2006 Feb;22(1):64-70.
10
An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.κ-阿片受体激动剂PD117,302的心脏作用研究。
Eur J Pharmacol. 2015 Aug 15;761:330-40. doi: 10.1016/j.ejphar.2015.06.018. Epub 2015 Jun 15.

引用本文的文献

1
Pharmacological and toxicological activity of RSD921, a novel sodium channel blocker.RSD921 一种新型钠离子通道阻滞剂的药理学和毒理学活性。
Biomed Pharmacother. 2018 Oct;106:510-522. doi: 10.1016/j.biopha.2018.06.157. Epub 2018 Jul 11.
2
Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists.基于阿片受体激动剂的心脏保护和抗心律失常药物的研发前景
Med Res Rev. 2016 Sep;36(5):871-923. doi: 10.1002/med.21395. Epub 2016 May 16.
3
The κ-opioid receptor agonist U-50488 blocks Ca2+ channels in a voltage- and G protein-independent manner in sensory neurons.
κ-阿片受体激动剂 U-50488 以电压和 G 蛋白非依赖的方式在感觉神经元中阻断 Ca2+通道。
Reg Anesth Pain Med. 2013 Jan-Feb;38(1):21-7. doi: 10.1097/AAP.0b013e318274a8a1.
4
Sex differences in U50,488H-induced phosphorylation of p44/42 mitogen-activated protein kinase in the guinea pig brain.U50,488H 诱导的豚鼠脑内 p44/42 丝裂原活化蛋白激酶磷酸化的性别差异。
Neuroscience. 2012 Oct 25;223:447-56. doi: 10.1016/j.neuroscience.2012.07.040. Epub 2012 Jul 31.
5
Potent and use-dependent block of cardiac sodium channels by U-50,488H, a benzeneacetamide kappa opioid receptor agonist.苯乙酰胺κ阿片受体激动剂U-50,488H对心脏钠通道具有强效且依赖使用的阻滞作用。
Exp Clin Cardiol. 2001 Summer;6(2):61-71.
6
Cardioprotective and antiarrhythmic effect of U50,488H in ischemia/reperfusion rat heart.U50,488H对缺血/再灌注大鼠心脏的心脏保护和抗心律失常作用。
Heart Vessels. 2007 Sep;22(5):335-44. doi: 10.1007/s00380-007-0983-z. Epub 2007 Sep 20.
7
Molecular analysis of the Na+ channel blocking actions of the novel class I anti-arrhythmic agent RSD 921.新型I类抗心律失常药物RSD 921对钠离子通道阻断作用的分子分析
Br J Pharmacol. 1999 May;127(1):9-18. doi: 10.1038/sj.bjp.0702488.
8
Modulation of the induction of ornithine decarboxylase by some opioid receptor agonists in immune cells and cardiomyocytes.某些阿片受体激动剂对免疫细胞和心肌细胞中鸟氨酸脱羧酶诱导的调节作用。
Mol Cell Biochem. 1998 Aug;185(1-2):47-53. doi: 10.1023/a:1006857027551.